FORA Capital’s Zymeworks ZYME Stock Holding History

FORA Capital’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,337	Closed	-$42K	–	1191
2021 Q1	$42K	Sell	1,337 -771	-37%	-$31.3K	0.01%	577
2020 Q4	$100K	Buy	+2,108	New	+$97.9K	0.02%	669

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

FORA Capital's ZYME Position: Q2 2021 in Review

FORA Capital sold out of Zymeworks (ZYME) in Q2 2021, closing a stake of 1,337 shares — an estimated $42K sold.

FORA Capital first reported a position in ZYME in Q4 2020 and held it in 2 quarters. The position peaked at $100K in Q4 2020. 109 funds tracked by Wall St. Rank hold ZYME as of Q2 2021.

FORA Capital reported no remaining Zymeworks position as of Q2 2021 after selling out during the quarter.
FORA Capital sold 1,337 Zymeworks shares in Q2 2021, an estimated $42K.
FORA Capital first reported a position in Zymeworks in Q4 2020 and held it in 2 quarters.
FORA Capital's Zymeworks position peaked at $100K in Q4 2020.
109 funds tracked by Wall St. Rank held Zymeworks as of Q2 2021.

Based on FORA Capital's 13F filing for Q2 2021, filed 16 Aug 2021.